![](https://leitat.org/wp-content/uploads/2018/09/2b58da48-5359-4f30-a67f-08753f7474e8-original.jpeg)
Leitat in Biospain 2018!
Leitat in Biospain 2018! Around 100 companies and entities from the BioRegion of Catalonia participated in Biospain 2018, one of
Leitat in Biospain 2018! Around 100 companies and entities from the BioRegion of Catalonia participated in Biospain 2018, one of
The Innovative Medicines Initiative (IMI) is celebrating its 10th anniversary with a high-level event. Organized jointly by IMI together with
Next Thursday, on June 28th, Nanomed Spain collaborates with FENIN and the Plataforma de Tecnologías Sanitaria in the organization of
Today, Friday, 8th June is Batten Disease Family Association Awareness Day. Saturday 9th is International Batten Disease Awareness Day. You
The OActive project intends to make a significant leap forward adopting a multi-scale holistic analysis where patient-specific information from various
INMUNOSIGHT Immunological and molecular characterization in liquid biopsy of lung cancer patients for immunotherapy ABSTRACT The main objective of the
The HelloAI Summer School will take place in various places in Europe in June: in Budapest (4-6 June), in Stockholm
On the 25th and 26th of April, the consortium of the project nTRACK met in Athens after 6 months of
On the 12th of April, CIMTI and CIMIT in Boston jointly organize a conference entitled «Investment in Innovative Medical Technologies,»
Within the framework of the BATCure project in which Leitat participates, the scientific coordinator Professor Sara Mole from UCL gave
The OActive project, in which Leitat participates, aims to transform and accelerate the diagnosis and prediction of osteoarthritis. With the
CIMTI (Center for the Integration of Medicine and Innovative Technologies) has selected four projects to support their development and commercialization.
Along with Materials Helix leaders, LEITAT Technological Centre and the British Embassy, Vision2020 will be holding a Biomedicine/Health event in
Along with Materials Helix leaders, LEITAT, the TEC-SALUT Community, the Foreign & Commonwealth Office, and Vision2020 are organising a Health
WECANN Origin, genetic, chemical and morphological variability and traditional uses of Cannabis: bases for its new applications ABSTRACT Hemp (Cannabis
GRACIOUS Grouping, Read-Across, Characterisation and Classification Framework for Regulatory Risk Assessment of Manufactured Nanomaterials and Safer Design of nano-enabled Products
Sede Central Leitat
C/ de la Innovació, 2
08225 Terrassa, (Barcelona)
Tel. (+34) 937 882 300